Patents by Inventor Han Oh Park

Han Oh Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200056010
    Abstract: The present invention relates to an epoxy paste composition including silver-coated copper nanowires having a core-shell structure, and a conductive film including the same.
    Type: Application
    Filed: October 31, 2017
    Publication date: February 20, 2020
    Inventors: Han Oh PARK, Jae Ha KIM, Jun Pyo KIM, Jieun KIM
  • Publication number: 20200024592
    Abstract: The present invention relates to a method for preparing highly active silica magnetic nanoparticles, highly active silica magnetic nanoparticles prepared by the method, and a method of isolating nucleic acid using the highly active silica magnetic nanoparticles. The highly active silica magnetic nanoparticles prepared according to the present invention contain magnetic nanoparticles completely coated with silica, can be used as a reagent for isolating biomaterials, particularly, nucleic acids, and can isolate and purify nucleic acid in a high yield.
    Type: Application
    Filed: September 27, 2019
    Publication date: January 23, 2020
    Inventors: Han Oh PARK, Jae Ha KIM, Jong Gwang PARK
  • Publication number: 20190393022
    Abstract: A sample plate for MALDI mass spectrometry, according to the present invention, enables separately positioning, by means of a plastic insulation plate, metal wiring and metal dots onto which an analyte sample is to be loaded, and electrically connecting same by means of a via or a metal portion, and thus the energy transferred into the plate when radiating a laser beam on the target(metal dots) may be reduced compared to a sample plate using a base metal, and thus laser energy may be concentrated on the target, and an effect may be achieved whereby heat loss is minimized.
    Type: Application
    Filed: February 14, 2018
    Publication date: December 26, 2019
    Inventors: Taeman Kim, Jong Rok Ahn, Dohoon Kim, Han-Oh Park
  • Patent number: 10465184
    Abstract: The present invention relates to a method for preparing highly active silica magnetic nanoparticles, highly active silica magnetic nanoparticles prepared by the method, and a method of isolating nucleic acid using the highly active silica magnetic nanoparticles. The highly active silica magnetic nanoparticles prepared according to the present invention contain magnetic nanoparticles completely coated with silica, can be used as a reagent for isolating biomaterials, particularly, nucleic acids, and can isolate and purify nucleic acid in a high yield.
    Type: Grant
    Filed: September 15, 2015
    Date of Patent: November 5, 2019
    Assignee: BIONEER CORPORATION
    Inventors: Han Oh Park, Jae Ha Kim, Jong Gwang Park
  • Patent number: 10441957
    Abstract: The present invention relates to a magnetic particle separating device, and a method of separating and purifying nucleic acid or protein using the same. The device comprises: induction magnets (100); an induction magnet fixing part (200) having induction magnet fixing holes (210) for fixing the induction magnets (100); and a body (300) in which entry holes (310) are formed into which tubes (T) are inserted. Thus, the application and removal of a magnetic field to and from the body is made very convenient, so that the device can be very advantageously used in the separation and purification of nucleic acid or protein.
    Type: Grant
    Filed: December 5, 2014
    Date of Patent: October 15, 2019
    Assignee: BIONEER CORPORATION
    Inventors: Han Oh Park, Jong Kab Kim
  • Publication number: 20190279853
    Abstract: The present invention relates to a matrix-assisted laser desorption ionization mass spectrometry method and, specifically, a mass spectrometry method according to the present invention comprises the steps of: acquiring a mass spectrum of an analyte by performing matrix-assisted laser desorption ionization of the analyte, wherein a detection spectrum, which is the mass spectrum of the analyte, is acquired using each of two or more matrixes different from one another; and removing, from each detection spectrum, a peak of a corresponding matrix to obtain a matrix-removed spectrum, and then acquiring a corrected mass spectrum of the analyte on the basis of a matrix-removed spectrum for each of different matrixes.
    Type: Application
    Filed: October 30, 2017
    Publication date: September 12, 2019
    Inventors: Taeman KIM, Do Hoon KIM, Jong Rok AHN, Han-Oh PARK
  • Publication number: 20190227091
    Abstract: A biological sample processing apparatus, including: a pipette block with which a plurality of pipettes for sucking or discharging a biological sample in a multi-well plate in which wells are arranged in a matrix shape along row and column directions are detachably coupled; a pipette block forward and backward transfer unit configured to move the pipette block along a forward and backward direction along a process direction; a pipette block top and bottom transfer unit configured to move the pipette block along a vertical direction; a magnetic field applying unit disposed below the multi-well plate for applying a magnetic field to a well of the multi-well plate; and a heating unit disposed below the multi-well plate so as to be spaced apart from the magnetic field applying unit, for heating a well of the multi-well plate.
    Type: Application
    Filed: September 28, 2017
    Publication date: July 25, 2019
    Applicant: BIONEER CORPORATION
    Inventors: Han Oh PARK, Yang Won LEE, Jin IL LEE, Jung Do KIM, Dae Jin JANG, Jong Kab KIM
  • Publication number: 20190218555
    Abstract: The present invention relates to a pharmaceutical composition for treatment of cancer, which comprises, as an active ingredient, one or more miRNAs selected from the group consisting of miR-3670, miR-8078, and miR-4477a. The pharmaceutical composition for treatment of cancer according to the present invention exhibits excellent effects of inhibiting cancer cell proliferation and inducing cancer cell apoptosis. Thus, the pharmaceutical composition of the present invention can be effectively used as an anticancer therapeutic agent.
    Type: Application
    Filed: March 31, 2019
    Publication date: July 18, 2019
    Inventors: Taewoo Lee, Sanghyung Shim, Ungsik Yu, Han Oh Park
  • Patent number: 10351849
    Abstract: The present invention relates to a pharmaceutical composition for treatment of cancer, which comprises, as an active ingredient, one or more miRNAs selected from the group consisting of miR-3670, miR-8078, and miR-4477a. The pharmaceutical composition for treatment of cancer according to the present invention exhibits excellent effects of inhibiting cancer cell proliferation and inducing cancer cell apoptosis. Thus, the pharmaceutical composition of the present invention can be effectively used as an anticancer therapeutic agent.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: July 16, 2019
    Assignee: BIONEER CORPORATION
    Inventors: Taewoo Lee, Sanghyung Shim, Ungsik Yu, Han Oh Park
  • Publication number: 20190172603
    Abstract: The present invention relates to silver-coated copper nanowires having a core-shell structure using chemical reduction and a method of preparing the same. More particularly, the present invention relates to a method of preparing silver-coated copper nanowires including chemically producing copper nanowires and coating the surface of the copper with silver using a silver-ammonia complex solution and a reducing agent in order to prevent oxidation of the copper nanowires by chemical reduction, and silver-coated copper nanowires having a core-shell structure produced by the method. In addition, production costs can be reduced because copper nanowires can be produced by reusing solutions.
    Type: Application
    Filed: May 30, 2017
    Publication date: June 6, 2019
    Inventors: Han Oh Park, Jae Ha Kim, Jun Pyo Kim, Kug Jin Yun
  • Patent number: 10287542
    Abstract: An automated cell-free protein production system comprises: a protein expression reaction unit comprising a reaction vessel that includes a plurality of dialysis tubes, each including a dialysis membrane and being open at its top; a reaction temperature control unit configured to heat or cool the reaction vessel; a pipette array comprising a plurality of pipettes and configured to suck or discharge solutions using the pipettes; a pipette array moving unit configured to move the pipette array in an upward and downward direction, a forward and backward direction or a left and right direction so as to move solutions; a protein purification unit including a magnetic field application device; and a multi-well plate mounting unit having mounted therein a multi-well plate kit configured to supply solutions that are used for protein production.
    Type: Grant
    Filed: November 29, 2013
    Date of Patent: May 14, 2019
    Assignee: BIONEER CORPORATION
    Inventors: Han Oh Park, Jong Kab Kim, Ji Won Han, You Sang Cho, Min Jung Kim, Ha Neul Kim, Yang Won Lee, Nam Il Kim
  • Patent number: 10249404
    Abstract: A ceramic paste composition including carbon nanotubes or a carbon nanotube-metal composite and a silicone adhesive, wherein the silicone adhesive includes 0.1 to 10 wt % of a silanol group, and has a mole ratio of a phenyl group to a methyl group of 0.3 to 2.5. The ceramic paste composition has low sheet resistance, through which an excellent heat generating property, and shielding, absorbing and conducting properties may be implemented in one or more embodiments. Further, though the ceramic paste composition has a very high heat generating temperature of 400° C., as compared with general paste based on carbon nanotubes, the physical properties thereof may be maintained stably. In addition, the ceramic paste may be widely used in various fields including heat generating products such as those for keeping warmth or heating, and products for electromagnetic wave shielding and absorption, electrodes, electronic circuits, antennas, and the like.
    Type: Grant
    Filed: July 9, 2014
    Date of Patent: April 2, 2019
    Assignee: BIONEER CORPORATION
    Inventors: Han Oh Park, Jae Ha Kim, Jun Pyo Kim
  • Publication number: 20190076843
    Abstract: Provided is a low heat capacity composite for a thermal cycler. The low heat capacity composite of the present invention is a low heat capacity composite for a thermal cycler capable of overcoming difficulty in manufacture and reproducibility due to uniqueness of the existing PCR thermal cycler only. The low heat capacity composite of the present invention can reduce the cost of raw material and retain excellent heat property due to the improvement in low heat capacity and physical and mechanical properties, thereby remarkably shortening PCR reaction time and saving energy when used as a thermal block for a thermal cycler.
    Type: Application
    Filed: November 12, 2018
    Publication date: March 14, 2019
    Applicant: BIONEER CORPORATION
    Inventors: Han Oh PARK, Jae Ha KIM
  • Patent number: 10208309
    Abstract: The present invention relates to a novel siRNA, and a high-efficiency double-stranded oligo RNA structure containing the same, and a nanoparticle containing the high-efficiency double-stranded oligo RNA structure. The double-stranded oligo RNA structure has a structure in which a hydrophilic material and a hydrophobic material are conjugated to both ends of a double-stranded oligo RNA (siRNA) via a simple covalent bond or linker-mediated covalent bond in order to be efficiently delivered into cells, and may be converted into a nanoparticle form in an aqueous solution by hydrophobic interactions of double-stranded oligo RNA structures. It is preferable that the siRNA contained in the double-stranded oligo RNA structure is an siRNA specific for fibrosis or respiratory disease-related gene, particularly, amphiregulin or stratifin.
    Type: Grant
    Filed: April 6, 2015
    Date of Patent: February 19, 2019
    Assignee: BIONEER CORPORATION
    Inventors: Jeiwook Chae, Pyoung Oh Yoon, Boram Han, Mi Na Kim, Youngho Ko, Han Oh Park
  • Patent number: 10144972
    Abstract: A composition for hot-start reverse transcription reaction and a composition for reverse transcription PCR are disclosed. The composition is obtained by adding pyrophosphate and pyrophosphatase to an aqueous solution containing reaction buffer solution, MgCl2, four kinds of dNTPs, and reverse transcription polymerase in a single reaction tube. The composition for hot-start reverse transcription reaction is obtained by freezing or drying the composition. The composition show increased stability and long-term storage stability. Also, disclosed is a composition that additionally includes DNA polymerase, and, thus, enables a hot-start reverse transcription reaction and a PCR reaction to be sequentially performed. A method for amplifying a nucleic acid by using the composition. The composition of the invention can be conveniently and effectively used in multiplex reverse transcription PCRs or real-time quantitative reverse transcription PCR.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: December 4, 2018
    Assignee: BIONEER CORPORATION
    Inventors: Han Oh Park, Jun Hee Lee, Sora Choi, Hyun Seo Kim
  • Patent number: 10030243
    Abstract: The present invention relates to an oligonucleotide structure and a method for preparing the same and, more particularly, to an oligonucleotide structure in which a polymer compound is linked to an oligonucleotide via a covalent bond to improve in vivo stability of the oligonucleotide and cellular delivery efficiency of the oligonucleotide; and to a method for preparing the same.
    Type: Grant
    Filed: July 4, 2014
    Date of Patent: July 24, 2018
    Assignee: BIONEER CORPORATION
    Inventors: Han Oh Park, Jeiwook Chae, Pyoung Oh Yoon, Boram Han, Gi-Eun Choi, Youngho Ko, Taewoo Kwon, Jae Don Lee, Sun Gi Kim
  • Patent number: 10022717
    Abstract: A method of manufacturing a micro-chamber plate with a built-in sample, including: settling a micro-chamber plate for sample injection at a micro-chamber plate receiving part formed with an upper opening; disposing a cover for micro-chamber plate receiving part to cover the upper opening, the cover for micro-chamber plate receiving part having a provisional storing part and an auxiliary covering part connected with the provisional storing part and formed with a through-hole for auxiliary covering part; and manufacturing a micro-chamber plate with a built-in sample by putting the micro-chamber plate receiving part, on which the cover is disposed, into a centrifugal separator which can apply vacuum, applying centrifugal force and injecting a sample solution provisionally stored in the provisional storing part into the micro-chamber plate through a vessel communication part which is formed at the provisional storing part to be communicated with the micro-chamber plate receiving part.
    Type: Grant
    Filed: October 5, 2015
    Date of Patent: July 17, 2018
    Assignee: BIONEER CORPORATION
    Inventors: Han Oh Park, Gu Young Song, Jung A Bae
  • Publication number: 20180030440
    Abstract: The present invention relates to a pharmaceutical composition for treatment of cancer, which comprises, as an active ingredient, one or more miRNAs selected from the group consisting of miR-3670, miR-8078, and miR-4477a. The pharmaceutical composition for treatment of cancer according to the present invention exhibits excellent effects of inhibiting cancer cell proliferation and inducing cancer cell apoptosis. Thus, the pharmaceutical composition of the present invention can be effectively used as an anticancer therapeutic agent.
    Type: Application
    Filed: February 25, 2016
    Publication date: February 1, 2018
    Inventors: Taewoo Lee, Sanghyung Shim, Ungsik Yu, Han Oh Park
  • Patent number: 9850530
    Abstract: The present invention relates to an automatic real-time quantitative amplification system which can perform analysis of various biological samples, and more particularly to an automatic real-time quantitative amplification system in which a plurality of decks for respectively accommodating biological samples are put in a deck storing/transferring device, whereby it is possible to automatically analyze an amount or existence of a target substance containing a target nucleic acid in the biologic sample, such as a particular gene, a particular, a particular pathogenic bacterium and a particular protein, by amplifying the target nucleic acid purified by some processes of purification, purification after culture, or purification after reaction of the target substance contained in the biological sample and then checking an amount of the amplified target nucleic acid.
    Type: Grant
    Filed: October 27, 2011
    Date of Patent: December 26, 2017
    Assignee: BIONEER CORPORATION
    Inventors: Han Oh Park, Kwon Sic Kim, Yang Won Lee, Jin Il Lee, Byung Rae Jeong, Jong Hoon Kim
  • Patent number: 9765383
    Abstract: Provided are an apparatus and a method for automatically analyzing biological samples capable of performing the entire processes of dissolving the biological samples in protease and cell lysate to dissolve a nucleic acid in a solution, attaching the nucleic acid to magnetic particles, finally washing the magnetic particle to which the nucleic acid is attached with an organic solvent, drying the magnetic particles using a vacuum pump, eluting the target nucleic acid attached to the magnetic particles in an aqueous solution, adding and mixing the eluted target nucleic acid into a vessel containing a nucleic acid amplification reagent, real-time detecting amplification by irradiating excitation light to a reactor simultaneously with regulating a temperature to perform amplification to measure fluorescence, inactivating an amplified product using an ultraviolet lamp after amplification, obtaining an image through electrophoresis, and analyzing a molecular weight in a single apparatus.
    Type: Grant
    Filed: February 7, 2013
    Date of Patent: September 19, 2017
    Assignee: BIONEER CORPORATION
    Inventors: Han Oh Park, Yang Won Lee, Jong-Kab Kim